Amedisys Closes Infinity HomeCare Acquisition
January 04 2016 - 7:00AM
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health
and hospice companies, today announced that on December 31, 2015,
it has closed the previously announced acquisition of Infinity
HomeCare, for $63 million in cash.
“By coming together, Amedisys and Infinity HomeCare will form
Florida’s premier home health company – with a focus on empowering
our employees to continue delivering outstanding, high-quality
patient care and partnering with the providers and communities we
serve,” stated Amedisys President and Chief Executive Officer Paul
Kusserow.
"Amedisys is recognized nationally for its leadership and
strategy for the future of healthcare at home,” said Infinity
HomeCare’s President and Chief Executive Officer Steve Karasick.
“Combining our organizations creates a unique and powerful team of
clinical excellence and innovation.”
Infinity HomeCare, headquartered in Sarasota, Florida, cares for
more than 14,000 patients per year and has more than 600 employees
with 15 care centers in Florida. The Company generates
approximately $50 million in annual revenues and was previously
controlled by the principals at HealthEdge Investment Partners,
LLC.
About Amedisys:
Amedisys, Inc. (NASDAQ:AMED) is a “health care at home” company
delivering personalized home health and hospice care to more than
360,000 patients each year. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
recovery and rehabilitation after an operation or injury, care
focused on empowering them to manage a chronic disease, palliative
care for those with a terminal illness, or hospice care at the end
of life. For more information about Amedisys, please visit:
http://www.amedisys.com.
We use our company website as a channel of distribution for
important company information. Important information, including
press releases, analyst presentations and financial information
regarding the Company is routinely posted on and accessible on the
“Investor Relations” subpage of our website, which is accessible by
clicking on the tab labeled “Investors” on our website home page.
We will also use our website to expedite public access to
time-critical information regarding the Company in advance of or in
lieu of distributing a press release or a filing with the
Securities and Exchange Commission (“SEC”) disclosing the same
information. In addition, we make available on the Investor
Relations subpage of our website (under the link “SEC filings”)
free of charge our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, ownership reports on
Forms 3, 4 and 5 and any amendments to those reports as soon as
practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our
Code of Ethical Business Conduct and the charters for the Audit,
Compensation, Nominating and Corporate Governance, Quality of Care
and Compliance and Ethics Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link “Corporate Governance”).
About
HealthEdge:
HealthEdge Investment Partners, LLC is an operating-oriented
private equity firm founded in 2005 that focuses exclusively on the
healthcare industry. HealthEdge seeks to achieve superior returns
by investing in businesses that benefit from the knowledge,
experience and network of relationships of its partners.
HealthEdge’s partners have more than 100 years of combined
operating experience in healthcare as CEOs and investors. For more
information on HealthEdge, visit www.healthedgepartners.com.
Media Contact:
Kendra Kimmons
Marketing & Communications
225-299-3720
kendra.kimmons@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024